(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 5.34% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.
Radnet's revenue in 2025 is $1,829,664,000.On average, 3 Wall Street analysts forecast RDNT's revenue for 2025 to be $142,709,186,158, with the lowest RDNT revenue forecast at $141,820,241,328, and the highest RDNT revenue forecast at $143,406,955,281.
In 2026, RDNT is forecast to generate $155,124,278,804 in revenue, with the lowest revenue forecast at $152,678,458,833 and the highest revenue forecast at $157,947,267,272.